The Patient Equation - de Vries, Glen
27,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
14 °P sammeln
  • Gebundenes Buch

HOW TO EMBRACE THE DATA REVOLUTION TO DELIVER FASTER, CHEAPER, AND MORE EFFECTIVE SOLUTIONS IN LIFE SCIENCES AND HEALTH CARE Digital transformation is changing the business of health care at breakneck speed--accelerated even further in the wake of COVID-19. Across the industry, from biotech and pharmaceutical companies to hospital systems, insurers, and more, everyone is looking for the next big technological innovations to develop new treatments, enhance care, improve outcomes, maximize efficiency, and increase value in our data-powered world. How did we get here, and what does the future…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
HOW TO EMBRACE THE DATA REVOLUTION TO DELIVER FASTER, CHEAPER, AND MORE EFFECTIVE SOLUTIONS IN LIFE SCIENCES AND HEALTH CARE Digital transformation is changing the business of health care at breakneck speed--accelerated even further in the wake of COVID-19. Across the industry, from biotech and pharmaceutical companies to hospital systems, insurers, and more, everyone is looking for the next big technological innovations to develop new treatments, enhance care, improve outcomes, maximize efficiency, and increase value in our data-powered world. How did we get here, and what does the future hold? The Patient Equation: The Precision Medicine Revolution in the Age of COVID-19 and Beyond explores the history, current state, and future direction of the use of data in biotechnology and health care. Author Glen de Vries, co-founder of the leading cloud platform for life sciences research, shares his insights and leadership on precision medicine and the digital landscape of the future. Designed to help anyone in the business of life sciences navigate our complex world, this practical guide explains the principles, approaches, and business models that are crucial for keeping pace with the ongoing revolution in data and analytics. Throughout the book, real-life stories show you what individuals and organizations are doing to ensure the data revolution does not pass them by, from wearables to track fertility to apps to conquer diabetes, from AI-powered sepsis alerts to using breakthrough new data strategies in clinical trials. A must-have resource for anyone interested in the future of life sciences and health care, The Patient Equation: * Covers the world of precision medicine, from the individual patient to the global population * Explains the fundamentals of patient equations and data collection and analysis * Discusses current progress and the most effective strategies to achieve future breakthroughs * Examines approaches to predicting and preventing disease using smart data * Illustrates why value-based reimbursement is the model of the future * Describes how data and technology will help us conquer everything from chronic conditions to cancer to rare diseases to pandemic illness
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
GLEN DE VRIES is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Medidata has powered tens of thousands of clinical trials, with millions of patients and billions of patient records. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen has been driving Medidata's mission since the company's inception in 1999, "powering smarter treatments and healthier people" by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. Glen's work has appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He also serves as a trustee of Carnegie Mellon University. JEREMY BLACHMAN is a writer who works with leaders across industries on getting their ideas out to the world. He has published two novels and developed television pilots for NBC. His writing has appeared in The New York Times, The Wall Street Journal, and many other prominent publications.